TR201911042T4 - Sinovit Tedavisinde veya Önlenmesinde Kullanım İçin Anti-İnflamatuar Fitobesinler. - Google Patents
Sinovit Tedavisinde veya Önlenmesinde Kullanım İçin Anti-İnflamatuar Fitobesinler. Download PDFInfo
- Publication number
- TR201911042T4 TR201911042T4 TR2019/11042T TR201911042T TR201911042T4 TR 201911042 T4 TR201911042 T4 TR 201911042T4 TR 2019/11042 T TR2019/11042 T TR 2019/11042T TR 201911042 T TR201911042 T TR 201911042T TR 201911042 T4 TR201911042 T4 TR 201911042T4
- Authority
- TR
- Turkey
- Prior art keywords
- synovitis
- prevention
- treatment
- compositions
- phytonutrients
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 3
- 201000004595 synovitis Diseases 0.000 title abstract 3
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 abstract 2
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 abstract 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 abstract 2
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 abstract 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 235000011576 oleuropein Nutrition 0.000 abstract 2
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 abstract 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 244000008991 Curcuma longa Species 0.000 abstract 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 abstract 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 abstract 1
- 235000003248 hydroxytyrosol Nutrition 0.000 abstract 1
- 229940095066 hydroxytyrosol Drugs 0.000 abstract 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 abstract 1
- 235000005875 quercetin Nutrition 0.000 abstract 1
- 229960001285 quercetin Drugs 0.000 abstract 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 abstract 1
- 235000005493 rutin Nutrition 0.000 abstract 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 abstract 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 abstract 1
- 229960004555 rutoside Drugs 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Sinovit tedavisi ya da önlenmesi için kompozisyonlar sağlanmaktadır. Kompozisyonlar, oleuropein, rutin ya da zerdeçaldan en az birisinin terapötik olarak etkili bir miktarını içerecek ve tercihen en azından oleuropein içerecektir. Sinovit tedavisi ya da önlenmesi için yöntemler de sağlanmıştır ve yöntemler, bu kompozisyonların uygulanmasını içerir. Kompozisyonlar ek olarak kuersetin, hidroksitirosol ya da D vitamininden biri ya da daha fazlasını içerebilir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361890626P | 2013-10-14 | 2013-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201911042T4 true TR201911042T4 (tr) | 2019-08-21 |
Family
ID=51663186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/11042T TR201911042T4 (tr) | 2013-10-14 | 2014-10-07 | Sinovit Tedavisinde veya Önlenmesinde Kullanım İçin Anti-İnflamatuar Fitobesinler. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20160263139A1 (tr) |
| EP (2) | EP3563855A1 (tr) |
| JP (1) | JP6588013B2 (tr) |
| CN (1) | CN105611935A (tr) |
| AU (1) | AU2014336465B2 (tr) |
| BR (1) | BR112016007462A2 (tr) |
| CA (1) | CA2923521C (tr) |
| ES (1) | ES2746071T3 (tr) |
| TR (1) | TR201911042T4 (tr) |
| WO (1) | WO2015055468A1 (tr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180139997A1 (en) * | 2015-06-15 | 2018-05-24 | Gexnano S.R.L. | Food supplement for use in a process of metabolic rebalancing |
| ITUB20154001A1 (it) * | 2015-09-15 | 2017-03-15 | Scotto Dabusco Anna | Metodo di integrazione dietetica e uso per la preparazione di prodotti per l'integrazione personalizzata. |
| AU2017270131B2 (en) * | 2016-05-27 | 2023-03-09 | Société des Produits Nestlé S.A. | Nutritional composition for treating or preventing impaired mobility |
| ES2968107T3 (es) * | 2017-11-08 | 2024-05-07 | Nestle Sa | Alcohol homovanílico (AHV), isómero de AHV, métodos de preparación de composiciones que comprenden dichos compuestos, y métodos de utilización de dichos compuestos |
| EP3706761B1 (en) * | 2017-11-08 | 2023-11-15 | Société des Produits Nestlé S.A. | Bioconversion of oleuropein |
| EP3706760B1 (en) * | 2017-11-08 | 2023-08-02 | Société des Produits Nestlé S.A. | Method of selecting a probiotic |
| JP2021502335A (ja) * | 2017-11-08 | 2021-01-28 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | オレウロペインの生物変換 |
| CN108686119A (zh) * | 2018-06-27 | 2018-10-23 | 陶燃 | 一种治疗痛风的药物组合物及其应用 |
| AU2020324628A1 (en) | 2019-08-02 | 2022-03-10 | Suntory Holdings Limited | Composition for cartilage regeneration promotion |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891865A (en) * | 1996-10-04 | 1999-04-06 | Wisconsin Alumni Research Foundation | Treatment of arthritic disease induced by infectious agents |
| EP1482909B1 (en) * | 2002-02-13 | 2018-07-04 | Creagri, Inc. | Method and composition for treatment of inflammation |
| FR2853549B1 (fr) * | 2003-04-11 | 2007-11-09 | Agronomique Inst Nat Rech | Composition nutritionnelle ou therapeutique contenant le compose oleuropeine ou l'un de ses derives |
| EP2040696B1 (en) * | 2006-07-14 | 2017-01-25 | DSM IP Assets B.V. | Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| JP2010522190A (ja) * | 2007-03-19 | 2010-07-01 | メタプロテオミクス， エルエルシー | 骨及び関節の健康を助成するための方法と組成物 |
| US20140227198A1 (en) * | 2013-02-13 | 2014-08-14 | GRADS Holdings LLLP | Shelf-stable olive extract-containing compositions and methods of use thereof |
| BR112015029611B1 (pt) * | 2013-05-29 | 2023-01-17 | Société Des Produits Nestlé S.A | Uso de uma composição compreendendo oleuropeína |
-
2014
- 2014-10-07 CN CN201480055101.7A patent/CN105611935A/zh active Pending
- 2014-10-07 WO PCT/EP2014/071452 patent/WO2015055468A1/en active Application Filing
- 2014-10-07 JP JP2016522750A patent/JP6588013B2/ja active Active
- 2014-10-07 ES ES14781539T patent/ES2746071T3/es active Active
- 2014-10-07 BR BR112016007462A patent/BR112016007462A2/pt not_active Application Discontinuation
- 2014-10-07 EP EP19175837.4A patent/EP3563855A1/en not_active Withdrawn
- 2014-10-07 TR TR2019/11042T patent/TR201911042T4/tr unknown
- 2014-10-07 AU AU2014336465A patent/AU2014336465B2/en active Active
- 2014-10-07 CA CA2923521A patent/CA2923521C/en active Active
- 2014-10-07 US US15/028,983 patent/US20160263139A1/en not_active Abandoned
- 2014-10-07 EP EP14781539.3A patent/EP3057597B8/en active Active
-
2023
- 2023-07-11 US US18/220,541 patent/US20240082281A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3057597B8 (en) | 2019-08-14 |
| CA2923521A1 (en) | 2015-04-23 |
| EP3057597B1 (en) | 2019-06-05 |
| WO2015055468A1 (en) | 2015-04-23 |
| JP6588013B2 (ja) | 2019-10-09 |
| EP3057597A1 (en) | 2016-08-24 |
| BR112016007462A2 (pt) | 2017-08-01 |
| CN105611935A (zh) | 2016-05-25 |
| ES2746071T3 (es) | 2020-03-04 |
| CA2923521C (en) | 2021-11-02 |
| AU2014336465A1 (en) | 2016-03-10 |
| EP3563855A1 (en) | 2019-11-06 |
| JP2016539090A (ja) | 2016-12-15 |
| US20160263139A1 (en) | 2016-09-15 |
| US20240082281A1 (en) | 2024-03-14 |
| AU2014336465B2 (en) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201911042T4 (tr) | Sinovit Tedavisinde veya Önlenmesinde Kullanım İçin Anti-İnflamatuar Fitobesinler. | |
| CY1123845T1 (el) | Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων | |
| CY1124407T1 (el) | Ενωσεις αναστολεα αυτοταξινης | |
| MD3209310T2 (ro) | Compoziții care conțin tulpini bacteriene | |
| MD3209381T2 (ro) | Compoziții care conțin tulpini bacteriene | |
| CL2018000429A1 (es) | Moduladores de la expresión de kras | |
| CL2019001292A1 (es) | Nuevos derivados de quinolina. | |
| CY1125205T1 (el) | Φαρμακευτικες συνθεσεις δραστικων απο θεραπευτικη αποψη ενωσεων | |
| CY1121653T1 (el) | C1-inh συνθεσεις και μεθοδοι για την προληψη και αγωγη διαταραχων συνδεομενων με ανεπαρκεια αναστολεα c1 εστερασης | |
| ZA201800056B (en) | Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders | |
| MX356368B (es) | Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades. | |
| TW201613887A (en) | Antiproliferative compounds and methods of use thereof | |
| UY36075A (es) | Derivados de tubulisina | |
| CR20120202A (es) | Métodos y composiciones para tratar cáncer | |
| EA201891340A1 (ru) | Лечение рака с использованием 2-дезокси-2-фтор-l-фукозы в комбинации с ингибитором контрольных точек | |
| BR112015011756A2 (pt) | inibidores da glutamase e métodos de uso | |
| SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
| CL2018000565A1 (es) | Compuestos derivados de piridinona dicarboxamida, inhibidores de bromodominio; composicion farmaceutica; combinacion farmaceutica; utiles en el tratamiento de enfermedades autoinmunitarias, inflamatorias, virales y cancer, entre otras. | |
| CL2015003595A1 (es) | Inhibidores/antiandrógenos novedosos de cyp17 | |
| MX2015010791A (es) | Metodos para tratar el cancer y prevenir la resistencia a farmacos. | |
| TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
| MX2019013808A (es) | Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer. | |
| MX2017002489A (es) | Agentes terapeuticos humanos. | |
| CL2015001202A1 (es) | Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer. | |
| BR112016027043A2 (pt) | Combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer |